Skip to main content
Top
Published in: Surgical Endoscopy 3/2011

01-03-2011 | Letter

From evidence to a day-to-day laparoscopic colectomy

Authors: Ernst Hanisch, Dimosthenis E. Ziogas

Published in: Surgical Endoscopy | Issue 3/2011

Login to get access

Excerpt

High-quality evidence for incorporating new medical devices, technology, and surgical techniques into public health care with safety, efficiency, and consideration for cost-effectiveness requires analysis [1]. Laparoscopic techniques have revolutionized surgery. Indeed, minimally invasive approaches that can dramatically improve a patient’s outcomes have been evolved rapidly over the past two decades. …
Literature
1.
go back to reference Cuschieri A, Tang B (2010) Human reliability analysis (HRA) techniques and observational clinical HRA. Minim Invasive Ther Allied Technol 19:12–17PubMedCrossRef Cuschieri A, Tang B (2010) Human reliability analysis (HRA) techniques and observational clinical HRA. Minim Invasive Ther Allied Technol 19:12–17PubMedCrossRef
2.
go back to reference Singla A, Simons JP, Carroll JE, Li Y, Ng SC, Tseng JF, Shah SA (2010) Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc 24:662–669PubMedCrossRef Singla A, Simons JP, Carroll JE, Li Y, Ng SC, Tseng JF, Shah SA (2010) Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc 24:662–669PubMedCrossRef
3.
go back to reference Neumann PJ, Tunis SR (2010) Medicare and medical technology: the growing demand for relevant outcomes. N Engl J Med. Epub ahead of print Neumann PJ, Tunis SR (2010) Medicare and medical technology: the growing demand for relevant outcomes. N Engl J Med. Epub ahead of print
4.
go back to reference Mushlin AI, Ghomrawi H (2010) Health care reform and the need for comparative-effectiveness research. N Engl J Med 362:e6PubMedCrossRef Mushlin AI, Ghomrawi H (2010) Health care reform and the need for comparative-effectiveness research. N Engl J Med 362:e6PubMedCrossRef
5.
go back to reference Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250CrossRef Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250CrossRef
6.
go back to reference Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249:695–696PubMedCrossRef Ziogas D, Polychronidis A, Kanellos I, Roukos D (2009) Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249:695–696PubMedCrossRef
7.
go back to reference Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22:1405–1406PubMedCrossRef Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22:1405–1406PubMedCrossRef
8.
go back to reference Bali C, Ziogas D, Roukos DH, Baltogiannis G (2010) Laparoscopic and robotic rectal cancer resection: expectations for improving oncological outcomes. Ann Surg 251:185–186CrossRef Bali C, Ziogas D, Roukos DH, Baltogiannis G (2010) Laparoscopic and robotic rectal cancer resection: expectations for improving oncological outcomes. Ann Surg 251:185–186CrossRef
9.
go back to reference Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476PubMedCrossRef Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476PubMedCrossRef
10.
go back to reference Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250:349–350PubMedCrossRef Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250:349–350PubMedCrossRef
11.
go back to reference Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22:1553–1555PubMedCrossRef Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22:1553–1555PubMedCrossRef
12.
go back to reference Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651CrossRef Roukos DH (2009) Laparoscopic gastrectomy and personal genomics: high-volume surgeons and predictive biomedicine may govern the future for resectable gastric cancer. Ann Surg 250:650–651CrossRef
14.
go back to reference Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9:1413–1416PubMedCrossRef Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9:1413–1416PubMedCrossRef
15.
go back to reference Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249:1067–1068PubMedCrossRef Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249:1067–1068PubMedCrossRef
16.
go back to reference Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16:1771–1782PubMedCrossRef Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16:1771–1782PubMedCrossRef
17.
go back to reference Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9:227–229PubMedCrossRef Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9:227–229PubMedCrossRef
18.
go back to reference Roukos DH (2010) Systems medicine: a real approach future personalized oncology? Pharmacogenomics 11(3):283–287PubMedCrossRef Roukos DH (2010) Systems medicine: a real approach future personalized oncology? Pharmacogenomics 11(3):283–287PubMedCrossRef
19.
go back to reference Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9:389–392PubMedCrossRef Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9:389–392PubMedCrossRef
20.
go back to reference Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17PubMedCrossRef Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17PubMedCrossRef
21.
22.
go back to reference Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7:719–726PubMedCrossRef Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7:719–726PubMedCrossRef
23.
go back to reference Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16:774–775PubMedCrossRef Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16:774–775PubMedCrossRef
24.
go back to reference Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545PubMedCrossRef Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545PubMedCrossRef
25.
go back to reference Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280PubMedCrossRef Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280PubMedCrossRef
26.
go back to reference Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678–2681PubMedCrossRef Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678–2681PubMedCrossRef
27.
go back to reference Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128PubMedCrossRef Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128PubMedCrossRef
28.
go back to reference Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48PubMedCrossRef Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48PubMedCrossRef
29.
go back to reference Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRef Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRef
Metadata
Title
From evidence to a day-to-day laparoscopic colectomy
Authors
Ernst Hanisch
Dimosthenis E. Ziogas
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 3/2011
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-010-1262-0

Other articles of this Issue 3/2011

Surgical Endoscopy 3/2011 Go to the issue